论文部分内容阅读
BACKGROUND:Chemoembolization with doxorubucin-eluting beads(DEB) has been used to treat hepatocellular carcinoma(HCC) since 2007. This study compared the efficacy and survival between transarterial chemoembolization(TACE) with DEB and conventional approac